Skip to content

Form 4 filed by Lappe Mark

Lappe Mark filed this Form 4 on INBX (Inhibrx Biosciences, Inc.) with 6 transaction rows and 1 holding row, accepted by EDGAR 2026-10-14 22:58:14 UTC.

Accession
0001366074-26-000006
Filed
2026-10-14
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: INBX · Inhibrx Biosciences, Inc. (CIK 2007919)

  • Lappe Mark director, officer (Chief Executive Officer)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-10-14P bought+2,470$84.0707743,018I By the Lappe Family Trust
Common Stock 2026-10-14P bought+2,470$84.9992745,488I By the Lappe Family Trust
Common Stock 2026-10-14P bought+100$85.76745,588I By the Lappe Family Trust
Common Stock 2026-10-14P bought+2,449$84.0707167,449I By Lappe Descendants' Trust
Common Stock 2026-10-14P bought+2,451$84.9992169,900I By Lappe Descendants' Trust
Common Stock 2026-10-14P bought+100$85.76170,000I By Lappe Descendants' Trust
Common Stock holding 54,865I The Mark Paul Lappe Roth IRA